Lion Point Capital, LP
35 holdingsFiling period: 2026-03-31Current AUM: $17.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | 4.5K | $1.4M | $1.4M | 7.86% | -- | 2026-03-31 |
| 2 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 67.5K | $1.3M | $1.2M | 7.15% | -- | 2026-03-31 |
| 3 | — | ROYALTY PHARMA PLC | 21.4K | $1.0M | $1.0M | 5.89% | -- | 2026-03-31 |
| 4 | MIST | MILESTONE PHARMACEUTICALS IN | 820.0K | $975K | $909K | 5.22% | +65.0K | 2026-03-31 |
| 5 | GERN | GERON CORP | 578.0K | $861K | $745K | 4.28% | -- | 2026-03-31 |
| 6 | SNDX | SYNDAX PHARMACEUTICALS INC | 36.0K | $840K | $685K | 3.93% | -- | 2026-03-31 |
| 7 | ARDX | ARDELYX INC | 128.7K | $770K | $636K | 3.65% | -- | 2026-03-31 |
| 8 | FENC | FENNEC PHARMACEUTICALS INC | 112.4K | $691K | $1.1M | 6.17% | -- | 2026-03-31 |
| 9 | BNTC | BENITEC BIOPHARMA INC | 62.0K | $660K | $726K | 4.17% | -- | 2026-03-31 |
| 10 | SRPT | SAREPTA THERAPEUTICS INC | 28.5K | $620K | $423K | 2.43% | -- | 2026-03-31 |
| 11 | IRON | DISC MEDICINE INC | 8.1K | $517K | $623K | 3.57% | -- | 2026-03-31 |
| 12 | CUE1 | CUE BIOPHARMA INC | 2.20M | $506K | $506K | 2.91% | -- | 2026-03-31 |
| 13 | CMPS | COMPASS PATHWAYS PLC | 80.0K | $442K | $907K | 5.21% | +22.0K | 2026-03-31 |
| 14 | — | BIOHAVEN LTD | 51.7K | $437K | $437K | 2.51% | -- | 2026-03-31 |
| 15 | LNTH | LANTHEUS HLDGS INC | 5.5K | $417K | $548K | 3.15% | -- | 2026-03-31 |
| 16 | JSPR | JASPER THERAPEUTICS INC | 465.0K | $407K | $293K | 1.68% | -- | 2026-03-31 |
| 17 | HUMA | HUMACYTE INC | 650.0K | $394K | $424K | 2.44% | +150.0K | 2026-03-31 |
| 18 | VTRS | VIATRIS INC | 27.7K | $374K | $486K | 2.79% | -- | 2026-03-31 |
| 19 | KURA | KURA ONCOLOGY INC | 46.0K | $373K | $413K | 2.37% | -- | 2026-03-31 |
| 20 | BBIO | BRIDGEBIO PHARMA INC | 5.0K | $371K | $400K | 2.30% | -- | 2026-03-31 |
| 21 | DYN | DYNE THERAPEUTICS INC | 18.0K | $326K | $453K | 2.60% | -- | 2026-03-31 |
| 22 | RCKT | ROCKET PHARMACEUTICALS INC | 86.0K | $307K | $267K | 1.53% | -- | 2026-03-31 |
| 23 | PCRX | PACIRA BIOSCIENCES INC | 13.5K | $305K | $356K | 2.05% | -- | 2026-03-31 |
| 24 | EWTX | EDGEWISE THERAPEUTICS INC | 9.1K | $286K | $349K | 2.00% | -- | 2026-03-31 |
| 25 | MLYS | MINERALYS THERAPEUTICS INC | 10.5K | $284K | $268K | 1.54% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2